Scott Fidel
Stock Analyst at Stephens & Co.
(2.69)
# 1,896
Out of 4,829 analysts
183
Total ratings
100%
Success rate
12.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners | Reiterates: Overweight | $22 | $14.52 | +51.52% | 4 | Apr 1, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $110.91 | +28.03% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $28.58 | +32.96% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $95.30 | +5.98% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $181.78 | +22.68% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $15.12 | +12.47% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $62.79 | +16.26% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $380.64 | +77.33% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $10.43 | +197.22% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $333.46 | +22.95% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $136.68 | +22.18% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $25.63 | -18.06% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $249.53 | +0.19% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $404.58 | +52.01% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $116.41 | -9.80% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $322.20 | -0.68% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $148.83 | -18.03% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $23.84 | +285.91% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $353.70 | -20.84% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $1.17 | +8,019.66% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $5.40 | -72.22% | 3 | Nov 11, 2022 |
Ardent Health Partners
Apr 1, 2025
Reiterates: Overweight
Price Target: $22
Current: $14.52
Upside: +51.52%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $110.91
Upside: +28.03%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $28.58
Upside: +32.96%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $95.30
Upside: +5.98%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $181.78
Upside: +22.68%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $15.12
Upside: +12.47%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $62.79
Upside: +16.26%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $380.64
Upside: +77.33%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $10.43
Upside: +197.22%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $333.46
Upside: +22.95%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $136.68
Upside: +22.18%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $25.63
Upside: -18.06%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $249.53
Upside: +0.19%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $404.58
Upside: +52.01%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $116.41
Upside: -9.80%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $322.20
Upside: -0.68%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $148.83
Upside: -18.03%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $23.84
Upside: +285.91%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $353.70
Upside: -20.84%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $1.17
Upside: +8,019.66%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $5.40
Upside: -72.22%